100 related articles for article (PubMed ID: 4060853)
1. Mouse response to influenza immunosomes.
Boudreault A; Thibodeau L
Vaccine; 1985 Sep; 3(3 Suppl):231-4. PubMed ID: 4060853
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
3. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
[TBL] [Abstract][Full Text] [Related]
5. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
[TBL] [Abstract][Full Text] [Related]
6. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1223-38. PubMed ID: 10195636
[TBL] [Abstract][Full Text] [Related]
7. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1239-50. PubMed ID: 10195637
[TBL] [Abstract][Full Text] [Related]
8. Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses.
Nerome K; Yoshioka Y; Ishida M; Okuma K; Oka T; Kataoka T; Inoue A; Oya A
Vaccine; 1990 Oct; 8(5):503-9. PubMed ID: 2251876
[TBL] [Abstract][Full Text] [Related]
9. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
Oxford JS; Schild GC; Potter CW; Jennings R
J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions.
Nicholson KG; Tyrrell DA; Harrison P; Potter CW; Jennings R; Clark A; Schild GC; Wood JM; Yetts R; Seagroatt V; Huggins A; Anderson SG
J Biol Stand; 1979 Apr; 7(2):123-36. PubMed ID: 479199
[No Abstract] [Full Text] [Related]
11. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
[TBL] [Abstract][Full Text] [Related]
12. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
Johansson BE; Matthews JT; Kilbourne ED
Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
[TBL] [Abstract][Full Text] [Related]
13. Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines.
Chen KS; Quinnan GV
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2779-84. PubMed ID: 3183627
[TBL] [Abstract][Full Text] [Related]
14. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus].
Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI
Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000
[TBL] [Abstract][Full Text] [Related]
15. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
Smith GE; Flyer DC; Raghunandan R; Liu Y; Wei Z; Wu Y; Kpamegan E; Courbron D; Fries LF; Glenn GM
Vaccine; 2013 Sep; 31(40):4305-13. PubMed ID: 23891795
[TBL] [Abstract][Full Text] [Related]
16. Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine.
Johansson BE; Kilbourne ED
Vaccine; 1991 May; 9(5):330-3. PubMed ID: 1872017
[TBL] [Abstract][Full Text] [Related]
17. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
Ennis FA; Yi-Hua Q; Schild GC
J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
[TBL] [Abstract][Full Text] [Related]
18. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
20. Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.
Yoshikawa T; Suzuki Y; Nomoto A; Sata T; Kurata T; Tamura Si
Vaccine; 2002 Nov; 21(1-2):60-6. PubMed ID: 12443663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
